Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 8.29516073 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 8.29516073 |
3 | negative regulation of cell killing (GO:0031342) | 5.75969653 |
4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.75969653 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.60989823 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.45224211 |
7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.45224211 |
8 | modulation by symbiont of host immune response (GO:0052553) | 5.45224211 |
9 | positive regulation by symbiont of host defense response (GO:0052509) | 5.45224211 |
10 | modulation by symbiont of host defense response (GO:0052031) | 5.45224211 |
11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.45224211 |
12 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.42142702 |
13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.15373807 |
14 | response to peptidoglycan (GO:0032494) | 5.15132640 |
15 | neutrophil activation involved in immune response (GO:0002283) | 5.12290312 |
16 | protein retention in ER lumen (GO:0006621) | 4.99230307 |
17 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.94823383 |
18 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.89627948 |
19 | positive regulation of nuclease activity (GO:0032075) | 4.87942942 |
20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.78703477 |
21 | protein maturation by protein folding (GO:0022417) | 4.77984810 |
22 | detection of other organism (GO:0098543) | 4.65389061 |
23 | macrophage activation involved in immune response (GO:0002281) | 4.55134241 |
24 | cellular extravasation (GO:0045123) | 4.51250195 |
25 | regulation of nuclease activity (GO:0032069) | 4.44306591 |
26 | detection of bacterium (GO:0016045) | 4.43925029 |
27 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.41526324 |
28 | regulation of translational fidelity (GO:0006450) | 4.31441406 |
29 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.26586473 |
30 | leukocyte aggregation (GO:0070486) | 4.23661595 |
31 | detection of molecule of bacterial origin (GO:0032490) | 4.22557111 |
32 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.15703962 |
33 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.10946926 |
34 | detection of external biotic stimulus (GO:0098581) | 4.10611017 |
35 | regulation of mast cell degranulation (GO:0043304) | 4.10503438 |
36 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.02963492 |
37 | cellular response to unfolded protein (GO:0034620) | 3.92944640 |
38 | regulation of gamma-delta T cell activation (GO:0046643) | 3.92019517 |
39 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.90178727 |
40 | response to muramyl dipeptide (GO:0032495) | 3.86967816 |
41 | DNA unwinding involved in DNA replication (GO:0006268) | 3.86507869 |
42 | regulation of leukocyte degranulation (GO:0043300) | 3.85662107 |
43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.84942987 |
44 | response to host immune response (GO:0052572) | 3.84942987 |
45 | negative regulation of interleukin-12 production (GO:0032695) | 3.84107010 |
46 | cellular response to topologically incorrect protein (GO:0035967) | 3.81376348 |
47 | neutrophil activation (GO:0042119) | 3.80899987 |
48 | vesicle coating (GO:0006901) | 3.77897736 |
49 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.72420472 |
50 | detection of biotic stimulus (GO:0009595) | 3.70665803 |
51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.70477080 |
52 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.70144079 |
53 | ER-nucleus signaling pathway (GO:0006984) | 3.69622846 |
54 | response to host (GO:0075136) | 3.65644256 |
55 | response to host defenses (GO:0052200) | 3.65644256 |
56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.65644256 |
57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.64697443 |
58 | respiratory burst (GO:0045730) | 3.60974496 |
59 | exocrine pancreas development (GO:0031017) | 3.60275441 |
60 | positive regulation of mast cell activation (GO:0033005) | 3.57710765 |
61 | COPII vesicle coating (GO:0048208) | 3.55516000 |
62 | positive regulation of histone deacetylation (GO:0031065) | 3.51354652 |
63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.47881306 |
64 | regulation of translational termination (GO:0006449) | 3.46719265 |
65 | positive regulation of B cell differentiation (GO:0045579) | 3.46600018 |
66 | macrophage activation (GO:0042116) | 3.45256344 |
67 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.44807471 |
68 | regulation of regulated secretory pathway (GO:1903305) | 3.44584839 |
69 | sodium ion export (GO:0071436) | 3.44328927 |
70 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.44265094 |
71 | granulocyte activation (GO:0036230) | 3.43214477 |
72 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.42361313 |
73 | pentose-phosphate shunt (GO:0006098) | 3.41709934 |
74 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.39277422 |
75 | myeloid cell activation involved in immune response (GO:0002275) | 3.39235155 |
76 | peptidyl-lysine dimethylation (GO:0018027) | 3.38103533 |
77 | neutrophil mediated immunity (GO:0002446) | 3.35934278 |
78 | oxaloacetate metabolic process (GO:0006107) | 3.35770071 |
79 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.34398337 |
80 | response to interleukin-15 (GO:0070672) | 3.34386272 |
81 | protein autoprocessing (GO:0016540) | 3.32270871 |
82 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.30480741 |
83 | translesion synthesis (GO:0019985) | 3.30348565 |
84 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.23816443 |
85 | microglial cell activation (GO:0001774) | 3.21389156 |
86 | regulation of mast cell activation (GO:0033003) | 3.20871953 |
87 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.18539453 |
88 | positive regulation of mast cell degranulation (GO:0043306) | 3.18539453 |
89 | nucleobase biosynthetic process (GO:0046112) | 3.17692007 |
90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.15812868 |
91 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.15235583 |
92 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.13596537 |
93 | regulation of B cell differentiation (GO:0045577) | 3.11577034 |
94 | negative regulation of phagocytosis (GO:0050765) | 3.10814984 |
95 | germinal center formation (GO:0002467) | 3.09930611 |
96 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.09682351 |
97 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.09682351 |
98 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 3.08775837 |
99 | UMP metabolic process (GO:0046049) | 3.08775837 |
100 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 3.08775837 |
101 | UMP biosynthetic process (GO:0006222) | 3.08775837 |
102 | B cell receptor signaling pathway (GO:0050853) | 3.05714770 |
103 | response to endoplasmic reticulum stress (GO:0034976) | 3.05037885 |
104 | negative regulation of T cell mediated immunity (GO:0002710) | 3.03644949 |
105 | response to pheromone (GO:0019236) | 3.02965727 |
106 | tetrahydrofolate metabolic process (GO:0046653) | 3.02195412 |
107 | immunoglobulin mediated immune response (GO:0016064) | 2.99616369 |
108 | heterochromatin organization (GO:0070828) | 2.97988889 |
109 | negative regulation of RNA splicing (GO:0033119) | 2.94994492 |
110 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.94389748 |
111 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.94137888 |
112 | dosage compensation (GO:0007549) | 2.93677468 |
113 | leukocyte degranulation (GO:0043299) | 2.92966562 |
114 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.91596477 |
115 | mannose metabolic process (GO:0006013) | 2.91391266 |
116 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.91086426 |
117 | positive regulation of regulated secretory pathway (GO:1903307) | 2.91008861 |
118 | ribosomal small subunit assembly (GO:0000028) | 2.90697320 |
119 | megakaryocyte development (GO:0035855) | 2.90219670 |
120 | regulation of erythrocyte differentiation (GO:0045646) | 2.90158291 |
121 | negative regulation of interleukin-6 production (GO:0032715) | 2.90019322 |
122 | maternal placenta development (GO:0001893) | 2.89912094 |
123 | positive regulation of protein deacetylation (GO:0090312) | 2.87942617 |
124 | tricarboxylic acid metabolic process (GO:0072350) | 2.87897477 |
125 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.86576693 |
126 | endosome to pigment granule transport (GO:0043485) | 2.86563149 |
127 | endosome to melanosome transport (GO:0035646) | 2.86563149 |
128 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.86414066 |
129 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.85995014 |
130 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.85583109 |
131 | regulation of macrophage cytokine production (GO:0010935) | 2.83423905 |
132 | response to unfolded protein (GO:0006986) | 2.83091727 |
133 | sequestering of metal ion (GO:0051238) | 2.80904925 |
134 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.79354134 |
135 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.78731503 |
136 | positive regulation of insulin secretion (GO:0032024) | 2.78040408 |
137 | negative regulation of mRNA metabolic process (GO:1903312) | 2.76691663 |
138 | response to topologically incorrect protein (GO:0035966) | 2.76569130 |
139 | regulation of ARF protein signal transduction (GO:0032012) | 2.76476446 |
140 | negative regulation of type 2 immune response (GO:0002829) | 2.76313261 |
141 | peptidyl-asparagine modification (GO:0018196) | 2.76123903 |
142 | myeloid leukocyte mediated immunity (GO:0002444) | 2.75967698 |
143 | negative regulation of innate immune response (GO:0045824) | 2.75730207 |
144 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.74938399 |
145 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 2.74681713 |
146 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.74649389 |
147 | proline biosynthetic process (GO:0006561) | 2.74628769 |
148 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.73813123 |
149 | positive thymic T cell selection (GO:0045059) | 2.73388657 |
150 | DNA strand elongation (GO:0022616) | 2.72373935 |
151 | positive regulation of Rap GTPase activity (GO:0032854) | 2.69381522 |
152 | positive regulation of leukocyte degranulation (GO:0043302) | 2.69321878 |
153 | neutrophil chemotaxis (GO:0030593) | 2.68381678 |
154 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.67200982 |
155 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.65900497 |
156 | 4-hydroxyproline metabolic process (GO:0019471) | 2.65287222 |
157 | defense response to protozoan (GO:0042832) | 2.64247688 |
158 | endocrine pancreas development (GO:0031018) | 2.64131740 |
159 | positive regulation of synapse maturation (GO:0090129) | 2.64072700 |
160 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.63652656 |
161 | cellular potassium ion homeostasis (GO:0030007) | 2.63105649 |
162 | response to laminar fluid shear stress (GO:0034616) | 2.63052239 |
163 | regulation of ARF GTPase activity (GO:0032312) | 2.62896266 |
164 | negative thymic T cell selection (GO:0045060) | 2.62105038 |
165 | NADPH regeneration (GO:0006740) | 2.61939578 |
166 | neutrophil migration (GO:1990266) | 2.60773220 |
167 | histone H4-K12 acetylation (GO:0043983) | 2.60590253 |
168 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.59568018 |
169 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.59568018 |
170 | cerebellar Purkinje cell layer development (GO:0021680) | 2.57921461 |
171 | regulation of platelet aggregation (GO:0090330) | 2.57792372 |
172 | platelet formation (GO:0030220) | 2.57227013 |
173 | histone arginine methylation (GO:0034969) | 2.56448867 |
174 | cellular response to interleukin-15 (GO:0071350) | 2.54714876 |
175 | peptidyl-arginine N-methylation (GO:0035246) | 2.54678540 |
176 | peptidyl-arginine methylation (GO:0018216) | 2.54678540 |
177 | DNA replication initiation (GO:0006270) | 2.54052199 |
178 | regulation of cholesterol homeostasis (GO:2000188) | 2.54035903 |
179 | peptide hormone processing (GO:0016486) | 2.51956362 |
180 | regulation of tolerance induction (GO:0002643) | 2.51560184 |
181 | DNA duplex unwinding (GO:0032508) | 2.51324981 |
182 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.50614783 |
183 | nitric oxide mediated signal transduction (GO:0007263) | 2.49989127 |
184 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.49746017 |
185 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.49652488 |
186 | protein-DNA complex disassembly (GO:0032986) | 2.48347732 |
187 | nucleosome disassembly (GO:0006337) | 2.48347732 |
188 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.47786765 |
189 | insulin secretion (GO:0030073) | 2.46213869 |
190 | embryonic hemopoiesis (GO:0035162) | 2.45960117 |
191 | DNA geometric change (GO:0032392) | 2.45147713 |
192 | negative regulation of cell size (GO:0045792) | 2.44547709 |
193 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.43877103 |
194 | protein N-linked glycosylation (GO:0006487) | 2.42859308 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.72499121 |
2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.10941818 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 3.73878461 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.56281366 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.22924014 |
6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.11627918 |
7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.91944562 |
8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.60463155 |
9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.58122014 |
10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54432723 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.52480111 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.34447701 |
13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32829935 |
14 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.28806508 |
15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.27178714 |
16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.11975872 |
17 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08703568 |
18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08488110 |
19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.05871265 |
20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01543851 |
21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.00662633 |
22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93699945 |
23 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.92707387 |
24 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.85916648 |
25 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.82864569 |
26 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81776685 |
27 | MAF_26560356_Chip-Seq_TH2_Human | 1.81411248 |
28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81100402 |
29 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78993571 |
30 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.77461918 |
31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74794536 |
32 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.74575662 |
33 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.74382795 |
34 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.74319794 |
35 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.74177394 |
36 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.74011016 |
37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70089540 |
38 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.68840757 |
39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.68709195 |
40 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66843724 |
41 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.66491426 |
42 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.65233479 |
43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.63744182 |
44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.63703112 |
45 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.63541075 |
46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62471857 |
47 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.61412755 |
48 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.60841853 |
49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.59788039 |
50 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.56759476 |
51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.53777055 |
52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.53429656 |
53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.53243948 |
54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52745122 |
55 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.51644404 |
56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51491041 |
57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.51170398 |
58 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.49922951 |
59 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.49044908 |
60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.47698978 |
61 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.47221078 |
62 | MYB_26560356_Chip-Seq_TH1_Human | 1.46912086 |
63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.46561519 |
64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46328134 |
65 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.46112768 |
66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.45436916 |
67 | MYB_26560356_Chip-Seq_TH2_Human | 1.45416576 |
68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.44309923 |
69 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43555048 |
70 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.43212393 |
71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.42304825 |
72 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.41306054 |
73 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.40836694 |
74 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.39210654 |
75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38368028 |
76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38347037 |
77 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.37207528 |
78 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37043983 |
79 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.36956734 |
80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36660454 |
81 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.36118159 |
82 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35338882 |
83 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35241968 |
84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34820890 |
85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33993552 |
86 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.33149316 |
87 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.33010059 |
88 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32458010 |
89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.32127691 |
90 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.30859160 |
91 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.30440056 |
92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29318221 |
93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28751323 |
94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.28076920 |
95 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27748255 |
96 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.27677186 |
97 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26303720 |
98 | P68_20966046_ChIP-Seq_HELA_Human | 1.24921454 |
99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22837081 |
100 | MAF_26560356_Chip-Seq_TH1_Human | 1.22761830 |
101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20633149 |
102 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20391733 |
103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20276627 |
104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.19354724 |
105 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.17936788 |
106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17812397 |
107 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17690909 |
108 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17596783 |
109 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.17488598 |
110 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.17300889 |
111 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17081078 |
112 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.16063080 |
113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16060948 |
114 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15494884 |
115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15443256 |
116 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.14923354 |
117 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14884531 |
118 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14315183 |
119 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13994297 |
120 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.13736677 |
121 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.12510177 |
122 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12197434 |
123 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11088034 |
124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10228560 |
125 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09786669 |
126 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.09623444 |
127 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.09419547 |
128 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08263217 |
129 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08016010 |
130 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07847559 |
131 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07684154 |
132 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07324440 |
133 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06300655 |
134 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06150207 |
135 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05140403 |
136 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.04954705 |
137 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04415762 |
138 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04096966 |
139 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04041661 |
140 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.04015468 |
141 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03961707 |
142 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.03771168 |
143 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03295549 |
144 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.03212303 |
145 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01299094 |
146 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01179272 |
147 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00644428 |
148 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00398271 |
149 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00273570 |
150 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00161696 |
151 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00141744 |
152 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98756985 |
153 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.98265987 |
154 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98224788 |
155 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.97423021 |
156 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97222413 |
157 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95406858 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.34535426 |
2 | MP0002877_abnormal_melanocyte_morpholog | 3.46479109 |
3 | MP0003123_paternal_imprinting | 3.38910807 |
4 | MP0003283_abnormal_digestive_organ | 3.16919012 |
5 | MP0001835_abnormal_antigen_presentation | 3.01964125 |
6 | MP0002419_abnormal_innate_immunity | 3.01815377 |
7 | MP0003172_abnormal_lysosome_physiology | 2.90985539 |
8 | MP0003183_abnormal_peptide_metabolism | 2.78794185 |
9 | MP0005220_abnormal_exocrine_pancreas | 2.75559003 |
10 | MP0003122_maternal_imprinting | 2.68305566 |
11 | MP0002909_abnormal_adrenal_gland | 2.66671399 |
12 | MP0010352_gastrointestinal_tract_polyps | 2.64697345 |
13 | MP0005025_abnormal_response_to | 2.53848097 |
14 | MP0008260_abnormal_autophagy | 2.53113861 |
15 | MP0005000_abnormal_immune_tolerance | 2.41539499 |
16 | MP0001944_abnormal_pancreas_morphology | 2.40606886 |
17 | MP0002396_abnormal_hematopoietic_system | 2.34568064 |
18 | MP0004808_abnormal_hematopoietic_stem | 2.33383228 |
19 | MP0002693_abnormal_pancreas_physiology | 2.29990321 |
20 | MP0001800_abnormal_humoral_immune | 2.27561662 |
21 | MP0003191_abnormal_cellular_cholesterol | 2.26116938 |
22 | MP0001533_abnormal_skeleton_physiology | 2.22698905 |
23 | MP0003300_gastrointestinal_ulcer | 2.19801809 |
24 | MP0002132_abnormal_respiratory_system | 2.18845501 |
25 | MP0002420_abnormal_adaptive_immunity | 2.17844549 |
26 | MP0002723_abnormal_immune_serum | 2.16196034 |
27 | MP0001819_abnormal_immune_cell | 2.15473399 |
28 | MP0005387_immune_system_phenotype | 2.12953574 |
29 | MP0001790_abnormal_immune_system | 2.12953574 |
30 | MP0008961_abnormal_basal_metabolism | 2.06731322 |
31 | MP0002452_abnormal_antigen_presenting | 2.04645067 |
32 | MP0006082_CNS_inflammation | 2.04542333 |
33 | MP0001545_abnormal_hematopoietic_system | 2.03937542 |
34 | MP0005397_hematopoietic_system_phenotyp | 2.03937542 |
35 | MP0009780_abnormal_chondrocyte_physiolo | 2.00904603 |
36 | MP0005451_abnormal_body_composition | 1.93122571 |
37 | MP0009785_altered_susceptibility_to | 1.86571621 |
38 | MP0005671_abnormal_response_to | 1.86147754 |
39 | MP0004264_abnormal_extraembryonic_tissu | 1.85762810 |
40 | MP0005464_abnormal_platelet_physiology | 1.81182802 |
41 | MP0003121_genomic_imprinting | 1.81151621 |
42 | MP0000013_abnormal_adipose_tissue | 1.80579591 |
43 | MP0003763_abnormal_thymus_physiology | 1.80561932 |
44 | MP0004947_skin_inflammation | 1.80467414 |
45 | MP0003693_abnormal_embryo_hatching | 1.76522369 |
46 | MP0010307_abnormal_tumor_latency | 1.71350247 |
47 | MP0003828_pulmonary_edema | 1.70481745 |
48 | MP0003111_abnormal_nucleus_morphology | 1.69458011 |
49 | MP0006054_spinal_hemorrhage | 1.68339900 |
50 | MP0003866_abnormal_defecation | 1.66705060 |
51 | MP0002148_abnormal_hypersensitivity_rea | 1.66134297 |
52 | MP0003868_abnormal_feces_composition | 1.66132060 |
53 | MP0000716_abnormal_immune_system | 1.64352906 |
54 | MP0002405_respiratory_system_inflammati | 1.62372315 |
55 | MP0003656_abnormal_erythrocyte_physiolo | 1.60834579 |
56 | MP0000678_abnormal_parathyroid_gland | 1.58403609 |
57 | MP0010094_abnormal_chromosome_stability | 1.57009086 |
58 | MP0000858_altered_metastatic_potential | 1.48854223 |
59 | MP0003075_altered_response_to | 1.48851299 |
60 | MP0004510_myositis | 1.48103153 |
61 | MP0003705_abnormal_hypodermis_morpholog | 1.43147214 |
62 | MP0002078_abnormal_glucose_homeostasis | 1.42675583 |
63 | MP0000003_abnormal_adipose_tissue | 1.41812332 |
64 | MP0002998_abnormal_bone_remodeling | 1.41402807 |
65 | MP0004957_abnormal_blastocyst_morpholog | 1.40310885 |
66 | MP0001845_abnormal_inflammatory_respons | 1.38922012 |
67 | MP0006072_abnormal_retinal_apoptosis | 1.37616066 |
68 | MP0009672_abnormal_birth_weight | 1.36880691 |
69 | MP0000465_gastrointestinal_hemorrhage | 1.36142581 |
70 | MP0002089_abnormal_postnatal_growth/wei | 1.35763409 |
71 | MP0001851_eye_inflammation | 1.35672324 |
72 | MP0005083_abnormal_biliary_tract | 1.35332129 |
73 | MP0009278_abnormal_bone_marrow | 1.33229653 |
74 | MP0010155_abnormal_intestine_physiology | 1.32549118 |
75 | MP0009840_abnormal_foam_cell | 1.32435841 |
76 | MP0005076_abnormal_cell_differentiation | 1.31921946 |
77 | MP0008469_abnormal_protein_level | 1.27954745 |
78 | MP0009333_abnormal_splenocyte_physiolog | 1.26189689 |
79 | MP0001730_embryonic_growth_arrest | 1.25783246 |
80 | MP0004043_abnormal_pH_regulation | 1.21406393 |
81 | MP0003943_abnormal_hepatobiliary_system | 1.19706968 |
82 | MP0000358_abnormal_cell_content/ | 1.19666348 |
83 | MP0003077_abnormal_cell_cycle | 1.18392572 |
84 | MP0005365_abnormal_bile_salt | 1.17985878 |
85 | MP0002234_abnormal_pharynx_morphology | 1.17038291 |
86 | MP0004858_abnormal_nervous_system | 1.16778506 |
87 | MP0002928_abnormal_bile_duct | 1.15418599 |
88 | MP0008007_abnormal_cellular_replicative | 1.14279449 |
89 | MP0003329_amyloid_beta_deposits | 1.13294472 |
90 | MP0003303_peritoneal_inflammation | 1.12292258 |
91 | MP0003959_abnormal_lean_body | 1.11480370 |
92 | MP0000490_abnormal_crypts_of | 1.10922145 |
93 | MP0003690_abnormal_glial_cell | 1.10836794 |
94 | MP0004883_abnormal_blood_vessel | 1.09447901 |
95 | MP0005390_skeleton_phenotype | 1.09425081 |
96 | MP0005379_endocrine/exocrine_gland_phen | 1.08331101 |
97 | MP0008004_abnormal_stomach_pH | 1.07659993 |
98 | MP0000604_amyloidosis | 1.07478839 |
99 | MP0004859_abnormal_synaptic_plasticity | 1.07442729 |
100 | MP0009764_decreased_sensitivity_to | 1.05932609 |
101 | MP0005164_abnormal_response_to | 1.05562802 |
102 | MP0005058_abnormal_lysosome_morphology | 1.03955756 |
103 | MP0000639_abnormal_adrenal_gland | 1.03759493 |
104 | MP0002080_prenatal_lethality | 1.02720504 |
105 | MP0005166_decreased_susceptibility_to | 1.01928182 |
106 | MP0008058_abnormal_DNA_repair | 1.00350729 |
107 | MP0000313_abnormal_cell_death | 0.99899868 |
108 | MP0000350_abnormal_cell_proliferation | 0.99295822 |
109 | MP0008877_abnormal_DNA_methylation | 0.98432849 |
110 | MP0001502_abnormal_circadian_rhythm | 0.96866601 |
111 | MP0004233_abnormal_muscle_weight | 0.96238230 |
112 | MP0002398_abnormal_bone_marrow | 0.95708918 |
113 | MP0003787_abnormal_imprinting | 0.94714113 |
114 | MP0003091_abnormal_cell_migration | 0.93960559 |
115 | MP0002970_abnormal_white_adipose | 0.93768654 |
116 | MP0001958_emphysema | 0.93722842 |
117 | MP0008874_decreased_physiological_sensi | 0.93034416 |
118 | MP0003119_abnormal_digestive_system | 0.92923868 |
119 | MP0001666_abnormal_nutrient_absorption | 0.91533219 |
120 | MP0001697_abnormal_embryo_size | 0.91055573 |
121 | MP0001849_ear_inflammation | 0.88782391 |
122 | MP0005448_abnormal_energy_balance | 0.88597340 |
123 | MP0004381_abnormal_hair_follicle | 0.88259175 |
124 | MP0005384_cellular_phenotype | 0.87849035 |
125 | MP0003953_abnormal_hormone_level | 0.87659090 |
126 | MP0000703_abnormal_thymus_morphology | 0.86625913 |
127 | MP0004197_abnormal_fetal_growth/weight/ | 0.84994330 |
128 | MP0003279_aneurysm | 0.84819520 |
129 | MP0002166_altered_tumor_susceptibility | 0.83797028 |
130 | MP0000598_abnormal_liver_morphology | 0.82952992 |
131 | MP0002722_abnormal_immune_system | 0.81974181 |
132 | MP0004811_abnormal_neuron_physiology | 0.81498705 |
133 | MP0001853_heart_inflammation | 0.80935925 |
134 | MP0003795_abnormal_bone_structure | 0.80589605 |
135 | MP0002933_joint_inflammation | 0.80278854 |
136 | MP0005621_abnormal_cell_physiology | 0.78705399 |
137 | MP0002086_abnormal_extraembryonic_tissu | 0.78505607 |
138 | MP0002019_abnormal_tumor_incidence | 0.77990989 |
139 | MP0003045_fibrosis | 0.77409553 |
140 | MP0001986_abnormal_taste_sensitivity | 0.76500058 |
141 | MP0003436_decreased_susceptibility_to | 0.76483744 |
142 | MP0000920_abnormal_myelination | 0.76451318 |
143 | MP0005646_abnormal_pituitary_gland | 0.76256409 |
144 | MP0005551_abnormal_eye_electrophysiolog | 0.75887079 |
145 | MP0002084_abnormal_developmental_patter | 0.75654902 |
146 | MP0009763_increased_sensitivity_to | 0.75220975 |
147 | MP0005310_abnormal_salivary_gland | 0.74813995 |
148 | MP0003448_altered_tumor_morphology | 0.72995625 |
149 | MP0000343_altered_response_to | 0.72569004 |
150 | MP0003566_abnormal_cell_adhesion | 0.70921771 |
151 | MP0002429_abnormal_blood_cell | 0.70413801 |
152 | MP0000689_abnormal_spleen_morphology | 0.70386846 |
153 | MP0008770_decreased_survivor_rate | 0.69916926 |
154 | MP0005187_abnormal_penis_morphology | 0.69834118 |
155 | MP0010368_abnormal_lymphatic_system | 0.69519321 |
156 | MP0009703_decreased_birth_body | 0.68698197 |
157 | MP0010386_abnormal_urinary_bladder | 0.68390186 |
158 | MP0003879_abnormal_hair_cell | 0.68197004 |
159 | MP0004130_abnormal_muscle_cell | 0.68126336 |
160 | MP0000685_abnormal_immune_system | 0.67854132 |
161 | MP0002009_preneoplasia | 0.67337635 |
162 | MP0003984_embryonic_growth_retardation | 0.66806425 |
163 | MP0001915_intracranial_hemorrhage | 0.66380765 |
164 | MP0003635_abnormal_synaptic_transmissio | 0.65589493 |
165 | MP0000249_abnormal_blood_vessel | 0.63904087 |
166 | MP0009765_abnormal_xenobiotic_induced | 0.62979447 |
167 | MP0001663_abnormal_digestive_system | 0.62740439 |
168 | MP0008438_abnormal_cutaneous_collagen | 0.52967734 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.47754607 |
2 | Recurrent abscess formation (HP:0002722) | 4.89913708 |
3 | Myositis (HP:0100614) | 4.87203958 |
4 | Recurrent bacterial skin infections (HP:0005406) | 4.68254076 |
5 | Abnormality of macrophages (HP:0004311) | 4.60272587 |
6 | Orchitis (HP:0100796) | 4.33617550 |
7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.11143018 |
8 | Spontaneous hematomas (HP:0007420) | 4.09613398 |
9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.02237382 |
10 | Optic neuritis (HP:0100653) | 3.86700366 |
11 | Retrobulbar optic neuritis (HP:0100654) | 3.86700366 |
12 | Hyperacusis (HP:0010780) | 3.84586186 |
13 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.73013165 |
14 | Insomnia (HP:0100785) | 3.68439174 |
15 | Hypoglycemic seizures (HP:0002173) | 3.58194090 |
16 | Gastrointestinal infarctions (HP:0005244) | 3.52124892 |
17 | Obstructive lung disease (HP:0006536) | 3.50302768 |
18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.50302768 |
19 | Stomatitis (HP:0010280) | 3.46959535 |
20 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.33434042 |
21 | Recurrent fungal infections (HP:0002841) | 3.29714377 |
22 | Peritonitis (HP:0002586) | 3.28797262 |
23 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.25143789 |
24 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.22605715 |
25 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.22605715 |
26 | Meningitis (HP:0001287) | 3.20695034 |
27 | Cellulitis (HP:0100658) | 3.20389967 |
28 | Mediastinal lymphadenopathy (HP:0100721) | 3.19825947 |
29 | Thrombocytosis (HP:0001894) | 3.15659030 |
30 | Increased IgE level (HP:0003212) | 3.10457451 |
31 | Recurrent skin infections (HP:0001581) | 3.10072991 |
32 | Gingival bleeding (HP:0000225) | 2.99402337 |
33 | Amyloidosis (HP:0011034) | 2.94962339 |
34 | Episodic fever (HP:0001954) | 2.92963642 |
35 | Symptomatic seizures (HP:0011145) | 2.92827510 |
36 | Urticaria (HP:0001025) | 2.89628009 |
37 | Hypoglycemic coma (HP:0001325) | 2.88660839 |
38 | Hand muscle atrophy (HP:0009130) | 2.86557879 |
39 | Visual hallucinations (HP:0002367) | 2.84337147 |
40 | Gingivitis (HP:0000230) | 2.84085741 |
41 | Late onset (HP:0003584) | 2.83702621 |
42 | Elfin facies (HP:0004428) | 2.76225085 |
43 | Papilledema (HP:0001085) | 2.75593250 |
44 | Hypercortisolism (HP:0001578) | 2.70047700 |
45 | Congenital stationary night blindness (HP:0007642) | 2.69884824 |
46 | Encephalitis (HP:0002383) | 2.69819560 |
47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.67990474 |
48 | Recurrent cutaneous fungal infections (HP:0011370) | 2.67990474 |
49 | Enlarged penis (HP:0000040) | 2.66361627 |
50 | Arterial thrombosis (HP:0004420) | 2.61972817 |
51 | Keratoconjunctivitis sicca (HP:0001097) | 2.60825742 |
52 | Chest pain (HP:0100749) | 2.60746975 |
53 | Vasculitis (HP:0002633) | 2.59981272 |
54 | Pulmonary embolism (HP:0002204) | 2.59671764 |
55 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.58043483 |
56 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.57704958 |
57 | Mucopolysacchariduria (HP:0008155) | 2.57704958 |
58 | Reticulocytosis (HP:0001923) | 2.57234499 |
59 | Macroorchidism (HP:0000053) | 2.53866849 |
60 | Purpura (HP:0000979) | 2.52566170 |
61 | Aplastic anemia (HP:0001915) | 2.49302042 |
62 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.48216674 |
63 | Hemoptysis (HP:0002105) | 2.47944478 |
64 | Gastrointestinal inflammation (HP:0004386) | 2.46922401 |
65 | Bowel diverticulosis (HP:0005222) | 2.41399591 |
66 | Anorexia (HP:0002039) | 2.40976651 |
67 | Abnormal platelet volume (HP:0011876) | 2.39243479 |
68 | Inflammation of the large intestine (HP:0002037) | 2.38452704 |
69 | Broad palm (HP:0001169) | 2.36664585 |
70 | Upper limb amyotrophy (HP:0009129) | 2.35679895 |
71 | Distal upper limb amyotrophy (HP:0007149) | 2.35679895 |
72 | Granulocytopenia (HP:0001913) | 2.34276244 |
73 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.33961340 |
74 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.33961340 |
75 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.33961340 |
76 | Renal duplication (HP:0000075) | 2.29351805 |
77 | Abnormality of the peritoneum (HP:0002585) | 2.27905450 |
78 | Increased cerebral lipofuscin (HP:0011813) | 2.26674637 |
79 | Keratoconjunctivitis (HP:0001096) | 2.25644226 |
80 | Slow saccadic eye movements (HP:0000514) | 2.22764329 |
81 | Depression (HP:0000716) | 2.22330253 |
82 | Acute lymphatic leukemia (HP:0006721) | 2.21645052 |
83 | Polygenic inheritance (HP:0010982) | 2.21104737 |
84 | Growth hormone excess (HP:0000845) | 2.20778678 |
85 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.20388066 |
86 | Loss of speech (HP:0002371) | 2.20021688 |
87 | Abnormality of the lower motor neuron (HP:0002366) | 2.19784789 |
88 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.18827142 |
89 | Panhypogammaglobulinemia (HP:0003139) | 2.18583612 |
90 | Renovascular hypertension (HP:0100817) | 2.18579627 |
91 | Leukocytosis (HP:0001974) | 2.16779005 |
92 | Impaired smooth pursuit (HP:0007772) | 2.16636259 |
93 | Impaired platelet aggregation (HP:0003540) | 2.15938898 |
94 | Abnormal platelet function (HP:0011869) | 2.15938898 |
95 | Severe short stature (HP:0003510) | 2.15798533 |
96 | Ketoacidosis (HP:0001993) | 2.14997762 |
97 | Hypochromic anemia (HP:0001931) | 2.14493142 |
98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.14486265 |
99 | Supranuclear gaze palsy (HP:0000605) | 2.12898518 |
100 | Generalized hyperpigmentation (HP:0007440) | 2.12555992 |
101 | Prolonged bleeding time (HP:0003010) | 2.12466877 |
102 | Petechiae (HP:0000967) | 2.12191014 |
103 | Prominent metopic ridge (HP:0005487) | 2.11533170 |
104 | Colitis (HP:0002583) | 2.11150739 |
105 | Recurrent viral infections (HP:0004429) | 2.09472158 |
106 | Pustule (HP:0200039) | 2.09131379 |
107 | Obstructive sleep apnea (HP:0002870) | 2.08403003 |
108 | Pulmonary infiltrates (HP:0002113) | 2.08375776 |
109 | Hypergammaglobulinemia (HP:0010702) | 2.08242086 |
110 | Ependymoma (HP:0002888) | 2.08136025 |
111 | Spinal canal stenosis (HP:0003416) | 2.08059773 |
112 | Dysostosis multiplex (HP:0000943) | 2.07651640 |
113 | Hypochromic microcytic anemia (HP:0004840) | 2.06160034 |
114 | Long toe (HP:0010511) | 2.05549258 |
115 | Pointed chin (HP:0000307) | 2.04689926 |
116 | Poikilocytosis (HP:0004447) | 2.04191606 |
117 | Abnormality of the intrinsic pathway (HP:0010989) | 2.02419348 |
118 | Syringomyelia (HP:0003396) | 2.01419878 |
119 | Spinal cord lesions (HP:0100561) | 2.01419878 |
120 | Severe visual impairment (HP:0001141) | 2.00327774 |
121 | Osteomyelitis (HP:0002754) | 1.99732523 |
122 | Sepsis (HP:0100806) | 1.98908347 |
123 | Menorrhagia (HP:0000132) | 1.97413376 |
124 | Resting tremor (HP:0002322) | 1.97044523 |
125 | Amaurosis fugax (HP:0100576) | 1.96642713 |
126 | Increased nuchal translucency (HP:0010880) | 1.95411591 |
127 | Cerebral aneurysm (HP:0004944) | 1.94983992 |
128 | Thin bony cortex (HP:0002753) | 1.94828239 |
129 | Hepatosplenomegaly (HP:0001433) | 1.94606863 |
130 | Broad face (HP:0000283) | 1.94236085 |
131 | Neoplasm of the heart (HP:0100544) | 1.93908665 |
132 | 11 pairs of ribs (HP:0000878) | 1.92802811 |
133 | Myocardial infarction (HP:0001658) | 1.90904401 |
134 | Epistaxis (HP:0000421) | 1.90839532 |
135 | Large for gestational age (HP:0001520) | 1.90075520 |
136 | Insulin resistance (HP:0000855) | 1.89635688 |
137 | Increased serum ferritin (HP:0003281) | 1.88683864 |
138 | Fatigue (HP:0012378) | 1.88175291 |
139 | EEG with generalized epileptiform discharges (HP:0011198) | 1.86456798 |
140 | Glomerulopathy (HP:0100820) | 1.86434885 |
141 | Microcytic anemia (HP:0001935) | 1.86225273 |
142 | Retinal atrophy (HP:0001105) | 1.85741073 |
143 | Agitation (HP:0000713) | 1.85677425 |
144 | Cutaneous melanoma (HP:0012056) | 1.82490822 |
145 | Truncal obesity (HP:0001956) | 1.82164901 |
146 | Dilatation of the ascending aorta (HP:0005111) | 1.81445863 |
147 | Cholecystitis (HP:0001082) | 1.81035151 |
148 | Abnormal gallbladder physiology (HP:0012438) | 1.81035151 |
149 | Acne (HP:0001061) | 1.80853699 |
150 | Disproportionate tall stature (HP:0001519) | 1.80103633 |
151 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.79606895 |
152 | Cheilitis (HP:0100825) | 1.79541409 |
153 | Abnormality of the endocardium (HP:0004306) | 1.78998249 |
154 | Testicular neoplasm (HP:0010788) | 1.78869341 |
155 | Neuronal loss in central nervous system (HP:0002529) | 1.78857433 |
156 | Ragged-red muscle fibers (HP:0003200) | 1.78708630 |
157 | Bruising susceptibility (HP:0000978) | 1.78197666 |
158 | Slender long bone (HP:0003100) | 1.77188668 |
159 | Epileptiform EEG discharges (HP:0011182) | 1.76013691 |
160 | Ankyloglossia (HP:0010296) | 1.75289543 |
161 | Hypertriglyceridemia (HP:0002155) | 1.75229118 |
162 | Increased IgM level (HP:0003496) | 1.75205491 |
163 | Poikiloderma (HP:0001029) | 1.75171391 |
164 | Abnormal number of erythroid precursors (HP:0012131) | 1.74333318 |
165 | Metaphyseal cupping (HP:0003021) | 1.74196462 |
166 | Hemorrhage of the eye (HP:0011885) | 1.73666758 |
167 | Acanthocytosis (HP:0001927) | 1.72384836 |
168 | Abnormality of reticulocytes (HP:0004312) | 1.71954825 |
169 | Acute hepatic failure (HP:0006554) | 1.71807559 |
170 | Abnormality of the anterior horn cell (HP:0006802) | 1.71084224 |
171 | Degeneration of anterior horn cells (HP:0002398) | 1.71084224 |
172 | Thrombophlebitis (HP:0004418) | 1.70935274 |
173 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.70064122 |
174 | Abnormality of T cell physiology (HP:0011840) | 1.69582639 |
175 | Viral hepatitis (HP:0006562) | 1.69301562 |
176 | Abnormality of glycolipid metabolism (HP:0010969) | 1.69167101 |
177 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.69167101 |
178 | Cervical subluxation (HP:0003308) | 1.67290237 |
179 | Limb hypertonia (HP:0002509) | 1.66860755 |
180 | Hypsarrhythmia (HP:0002521) | 1.66610414 |
181 | Central scotoma (HP:0000603) | 1.65993553 |
182 | Overriding aorta (HP:0002623) | 1.65660810 |
183 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.65542320 |
184 | Abnormality of the metopic suture (HP:0005556) | 1.64646378 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 3.85795779 |
2 | PASK | 3.79776059 |
3 | PKN2 | 3.75765075 |
4 | TRIB3 | 3.37306001 |
5 | EEF2K | 3.36782419 |
6 | ERN1 | 3.18069188 |
7 | SCYL2 | 3.05066843 |
8 | PRPF4B | 2.99166888 |
9 | FLT3 | 2.90389119 |
10 | IRAK4 | 2.79583153 |
11 | TAOK3 | 2.45623106 |
12 | MAP3K3 | 2.21424335 |
13 | BLK | 2.18047180 |
14 | TYK2 | 2.15086274 |
15 | PRKD3 | 2.05719401 |
16 | MAP3K10 | 2.01816216 |
17 | EPHB1 | 2.00841298 |
18 | RIPK1 | 1.91527189 |
19 | INSRR | 1.83766549 |
20 | HIPK2 | 1.80520368 |
21 | CSK | 1.76738263 |
22 | NEK1 | 1.72490314 |
23 | CDC7 | 1.68324780 |
24 | CAMKK1 | 1.64585235 |
25 | CAMKK2 | 1.57853720 |
26 | BRSK2 | 1.56923267 |
27 | PTK6 | 1.56895965 |
28 | MAP3K13 | 1.56828271 |
29 | FGR | 1.49632809 |
30 | TGFBR1 | 1.45691674 |
31 | BTK | 1.44089123 |
32 | HCK | 1.42549733 |
33 | SMG1 | 1.42123937 |
34 | DAPK1 | 1.41541525 |
35 | BRSK1 | 1.39105449 |
36 | MARK2 | 1.34323114 |
37 | IRAK2 | 1.32418984 |
38 | ALK | 1.30875896 |
39 | TSSK6 | 1.27649336 |
40 | CDK12 | 1.26701809 |
41 | MAP4K1 | 1.24879652 |
42 | TNK2 | 1.20129011 |
43 | ZAP70 | 1.19422614 |
44 | MAP2K3 | 1.19204514 |
45 | TAOK1 | 1.18755214 |
46 | JAK3 | 1.17594830 |
47 | CDK8 | 1.16567342 |
48 | SIK3 | 1.14129308 |
49 | MAP3K14 | 1.09874489 |
50 | RPS6KB2 | 1.08463407 |
51 | NEK2 | 1.07041271 |
52 | MAP3K1 | 1.06941302 |
53 | TBK1 | 1.05682784 |
54 | DAPK2 | 1.04085240 |
55 | PDPK1 | 1.03615401 |
56 | FES | 1.03212058 |
57 | PAK4 | 1.03114071 |
58 | ATR | 1.02092907 |
59 | PDK1 | 0.97491503 |
60 | SIK1 | 0.96752469 |
61 | JAK1 | 0.96497010 |
62 | NTRK3 | 0.91561328 |
63 | RPS6KA2 | 0.91461544 |
64 | MARK3 | 0.90300326 |
65 | PDGFRA | 0.89798726 |
66 | IRAK3 | 0.89111968 |
67 | PTK2 | 0.88034315 |
68 | BCKDK | 0.87746050 |
69 | LYN | 0.87504818 |
70 | RPS6KA4 | 0.86926672 |
71 | MAP3K7 | 0.85704210 |
72 | MTOR | 0.85097695 |
73 | CSF1R | 0.83841479 |
74 | RET | 0.83382195 |
75 | ICK | 0.81584550 |
76 | IKBKE | 0.81140095 |
77 | LCK | 0.80850400 |
78 | MAPK12 | 0.79861379 |
79 | TESK2 | 0.78404803 |
80 | SGK3 | 0.76068237 |
81 | IRAK1 | 0.75485719 |
82 | MAP3K11 | 0.75441964 |
83 | YES1 | 0.75364043 |
84 | MAP3K2 | 0.74857422 |
85 | JAK2 | 0.74669854 |
86 | CDK7 | 0.74626685 |
87 | BMX | 0.73591880 |
88 | KIT | 0.72339315 |
89 | EPHA3 | 0.71875579 |
90 | CAMK1D | 0.70655996 |
91 | PRKCH | 0.69600714 |
92 | STK10 | 0.68599920 |
93 | MAPK7 | 0.68577900 |
94 | CDK19 | 0.67803311 |
95 | PRKD2 | 0.67581863 |
96 | CDC42BPA | 0.67576450 |
97 | DYRK3 | 0.66437383 |
98 | LRRK2 | 0.66275220 |
99 | KSR2 | 0.66077511 |
100 | STK38 | 0.65849073 |
101 | ITK | 0.64434899 |
102 | UHMK1 | 0.63792597 |
103 | BRD4 | 0.63369098 |
104 | MINK1 | 0.63213157 |
105 | ARAF | 0.62192409 |
106 | RPS6KB1 | 0.61735810 |
107 | FYN | 0.61671143 |
108 | MAP3K8 | 0.61182572 |
109 | MAP3K6 | 0.61158697 |
110 | RAF1 | 0.61030074 |
111 | STK11 | 0.60704915 |
112 | SYK | 0.59241699 |
113 | BMPR2 | 0.58343050 |
114 | CDK4 | 0.58244310 |
115 | MAPK11 | 0.57742118 |
116 | FGFR3 | 0.56608413 |
117 | NTRK1 | 0.56295300 |
118 | PAK2 | 0.55972779 |
119 | TXK | 0.55853905 |
120 | TTN | 0.55169191 |
121 | EIF2AK1 | 0.53084885 |
122 | MAP2K4 | 0.52774961 |
123 | MAP2K6 | 0.51672121 |
124 | DYRK1B | 0.51352384 |
125 | CCNB1 | 0.51042320 |
126 | MOS | 0.49983737 |
127 | CHEK1 | 0.49699744 |
128 | PTK2B | 0.48883914 |
129 | MATK | 0.48278343 |
130 | SGK223 | 0.48065940 |
131 | SGK494 | 0.48065940 |
132 | CDK2 | 0.47645383 |
133 | RPS6KC1 | 0.46638600 |
134 | RPS6KL1 | 0.46638600 |
135 | TAOK2 | 0.46486179 |
136 | GRK6 | 0.45620040 |
137 | PAK6 | 0.45342633 |
138 | SIK2 | 0.44194507 |
139 | SGK2 | 0.44091477 |
140 | TEC | 0.43648059 |
141 | RPS6KA6 | 0.43434459 |
142 | KSR1 | 0.43094592 |
143 | CAMK1G | 0.42080542 |
144 | MAPK15 | 0.41934989 |
145 | WEE1 | 0.41455580 |
146 | PRKDC | 0.41149305 |
147 | MAPK14 | 0.40861141 |
148 | MAP2K2 | 0.40287402 |
149 | PRKG2 | 0.34916728 |
150 | CAMK1 | 0.34879843 |
151 | ATM | 0.34110664 |
152 | MAPKAPK3 | 0.32968788 |
153 | AKT1 | 0.31009065 |
154 | FGFR4 | 0.30392922 |
155 | MAPK1 | 0.30017764 |
156 | CAMK4 | 0.29952365 |
157 | RPS6KA1 | 0.27883252 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.87864851 |
2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.68964886 |
3 | DNA replication_Homo sapiens_hsa03030 | 2.65536606 |
4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.57009005 |
5 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.45121880 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.41137322 |
7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.29040074 |
8 | Insulin secretion_Homo sapiens_hsa04911 | 2.28129293 |
9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.21426503 |
10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.16136395 |
11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.14089513 |
12 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.11005396 |
13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87809370 |
14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.86541889 |
15 | Protein export_Homo sapiens_hsa03060 | 1.86255796 |
16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.79840562 |
17 | Tuberculosis_Homo sapiens_hsa05152 | 1.79406961 |
18 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.77202533 |
19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.76431352 |
20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.75835760 |
21 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.74697256 |
22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69358326 |
23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.68569857 |
24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.66809173 |
25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.65545742 |
26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64723954 |
27 | Mismatch repair_Homo sapiens_hsa03430 | 1.61159724 |
28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.59028878 |
29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.55847335 |
30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.51034137 |
31 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.43766750 |
32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.42337161 |
33 | Malaria_Homo sapiens_hsa05144 | 1.40770146 |
34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30787731 |
35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.30005602 |
36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.29804264 |
37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28944215 |
38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.28921648 |
39 | Base excision repair_Homo sapiens_hsa03410 | 1.28328321 |
40 | Phagosome_Homo sapiens_hsa04145 | 1.25914124 |
41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25249140 |
42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22870783 |
43 | Measles_Homo sapiens_hsa05162 | 1.21538945 |
44 | RNA transport_Homo sapiens_hsa03013 | 1.19360018 |
45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.19356703 |
46 | Influenza A_Homo sapiens_hsa05164 | 1.15438684 |
47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15082303 |
48 | Lysine degradation_Homo sapiens_hsa00310 | 1.14147279 |
49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13838251 |
50 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.13245373 |
51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12242784 |
52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11834661 |
53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.10698409 |
54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.09974390 |
55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09245263 |
56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09053305 |
57 | Spliceosome_Homo sapiens_hsa03040 | 1.08996650 |
58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08846069 |
59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08758964 |
60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.08735604 |
61 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.07560883 |
62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07268341 |
63 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04242194 |
64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03328426 |
65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03169812 |
66 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.02805923 |
67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.02743292 |
68 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.02621189 |
69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01388171 |
70 | Cocaine addiction_Homo sapiens_hsa05030 | 1.01258040 |
71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.99594870 |
72 | Endocytosis_Homo sapiens_hsa04144 | 0.99200633 |
73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.98156315 |
74 | Pertussis_Homo sapiens_hsa05133 | 0.97697804 |
75 | Allograft rejection_Homo sapiens_hsa05330 | 0.97675184 |
76 | Cell cycle_Homo sapiens_hsa04110 | 0.97668279 |
77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.97457537 |
78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.97107551 |
79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.96927654 |
80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96751119 |
81 | Insulin resistance_Homo sapiens_hsa04931 | 0.94812369 |
82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94299059 |
83 | Salmonella infection_Homo sapiens_hsa05132 | 0.93684744 |
84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.93207139 |
85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93094089 |
86 | Shigellosis_Homo sapiens_hsa05131 | 0.92937282 |
87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91640652 |
88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91573054 |
89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91114445 |
90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.88987131 |
91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.87571902 |
92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.87026455 |
93 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.86884927 |
94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.86559246 |
95 | Hepatitis C_Homo sapiens_hsa05160 | 0.86101044 |
96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85832345 |
97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85307681 |
98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84551780 |
99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84506596 |
100 | Amoebiasis_Homo sapiens_hsa05146 | 0.83623829 |
101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83534445 |
102 | Apoptosis_Homo sapiens_hsa04210 | 0.83503656 |
103 | Morphine addiction_Homo sapiens_hsa05032 | 0.83384390 |
104 | Bladder cancer_Homo sapiens_hsa05219 | 0.83063525 |
105 | ABC transporters_Homo sapiens_hsa02010 | 0.82692749 |
106 | Legionellosis_Homo sapiens_hsa05134 | 0.82076722 |
107 | Lysosome_Homo sapiens_hsa04142 | 0.82050037 |
108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81804183 |
109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80042482 |
110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80023277 |
111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79777876 |
112 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77270576 |
113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75748833 |
114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73049621 |
115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73049038 |
116 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.72880449 |
117 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.72280968 |
118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71768699 |
119 | Carbon metabolism_Homo sapiens_hsa01200 | 0.70883585 |
120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.70757829 |
121 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.70234937 |
122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69462396 |
123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69365023 |
124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68411796 |
125 | Glioma_Homo sapiens_hsa05214 | 0.66138243 |
126 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66127561 |
127 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65487147 |
128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65309828 |
129 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65196880 |
130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64807133 |
131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64510604 |
132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64353822 |
133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64286037 |
134 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.63717411 |
135 | Platelet activation_Homo sapiens_hsa04611 | 0.62932577 |
136 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62327818 |
137 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.58796114 |
138 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58087258 |
139 | RNA degradation_Homo sapiens_hsa03018 | 0.57861248 |
140 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57069935 |
141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56040643 |
142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54678524 |
143 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54424791 |
144 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53561411 |
145 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53459257 |
146 | Nicotine addiction_Homo sapiens_hsa05033 | 0.53311648 |
147 | Prion diseases_Homo sapiens_hsa05020 | 0.53079747 |
148 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52270363 |
149 | Alcoholism_Homo sapiens_hsa05034 | 0.51725698 |
150 | Gap junction_Homo sapiens_hsa04540 | 0.51473353 |
151 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50070941 |
152 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.49954174 |
153 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47979297 |
154 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47554325 |
155 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44904119 |
156 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44752141 |
157 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44524971 |
158 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43538470 |
159 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40602739 |
160 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40428760 |
161 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38508820 |
162 | Bile secretion_Homo sapiens_hsa04976 | 0.38387193 |
163 | Hepatitis B_Homo sapiens_hsa05161 | 0.38118274 |
164 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38089333 |